2022-RA-859-ESGO Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy vs. lymphadenectomy
Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Elisa Scarpelli(University of Parma), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Isabella Rotondella(University of Parma), Virginia Vargiu(Agostino Gemelli University Polyclinic), Diana Butera(University of Parma), Giulio Sozzi(University of Palermo), Alessandra de Finis(University of Parma), Giuseppe Barresi(University of Parma), Giuseppe Maglietta(University of Parma), Francesco Cosentino, Giulia Armano(University of Parma), Andrea Rosati(Agostino Gemelli University Polyclinic), Michela Gaiano(University of Parma), T. Ghi, Gabriella Celora(University of Parma), Luciano Monfardini(University of Parma), Francesco Fanfani(Agostino Gemelli University Polyclinic)
Cited by 0
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
<scp>ISUOG</scp> Practice Guidelines: performance of first‐trimester fetal ultrasound scan
|Ultrasound in Obstetrics and Gynecology|2012|619
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299